Research report
Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies

https://doi.org/10.1016/S0169-328X(97)00206-4Get rights and content

Abstract

Mouse monoclonal antibodies were raised against bacterially expressed protein sequences of the NR2A, NR2B, NR2C and NR2D subunits of the rat NMDA receptor. From immunoblots of rat brain proteins, the apparent molecular weights of these subunits were 165, 170, 135 and 145 kDa, respectively. Proteins of similar masses were observed on immunoblots of specifically transfected HEK293 cells. Deglycosylation with endoglycosidase F reduced the mass of each endogenous NR2 subunit by ≈10 kDa. In distribution studies, NR2A-immunoreactive protein (IRP) was located throughout the adult rat brain, NR2B-IRP was primarily in the forebrain, NR2C-IRP was predominantly in the cerebellum and NR2D-IRP was mainly found in the thalamus, midbrain and brainstem. Whereas NR2A- and NR2C-IRPs increased during rat brain post-natal development, NR2B- and NR2D-IRPs were abundant at birth and declined with age, especially in cerebellum. NR2-IRPs of mouse, rabbit, frog and human brain were of sizes similar to those of the corresponding rat subunits and were similarly distributed. In summary, NR2 subunits are large glycoproteins whose specific expression profiles in the brain are developmentally and regionally regulated and which are similarly expressed in a variety of species.

Introduction

The N-methyl-d-aspartate (NMDA) type of ionotropic glutamate receptor is physiologically important in excitatory neurotransmission and synaptic plasticity, and pathologically important in excitatory ischaemic neural death (see [33]for review). The rat, mouse and human genes encoding subunits of this receptor have been identified and classified into two related groups: the NMDAR1 (NR1 or ζ) subunit 20, 36, 41, 56and the NMDAR2 subunits A, B, C and D (NR2A–D or ϵ1–4) 17, 18, 23, 29, 34. Small channel responses can be detected from homomeric NR1 receptors recombinantly expressed in oocytes [36]but co-expression of NR2 subunits greatly enhances responses 18, 34. Thus, endogenous NMDA receptors are believed to be heteromeric assemblies containing NR1 subunits co-assembled with one, or perhaps more, type(s) of NR2 subunit 4, 9, 46, 52. The NR1 subunit is essential for NMDA receptor function since its absence prevents classical NMDA receptor responses both in recombinant expression systems [34]and in neurones cultured from the brains of mice lacking the NR1 gene [13].

Some heterogeneity of receptor function may be achieved by alternative splicing of the NR1 subunit mRNA. The insertion of a highly charged 21 amino-acid cassette into the N-terminal region of homomeric NR1 channels expressed in Xenopus oocytes prevents current potentiation by Zn2+ ions, alters pH sensitivity and mildly affects agonist and antagonist sensitivities while alternative C-termini produced by sequential cassette deletions may affect the regulation of NMDA channel function by protein kinase C 11, 12, 15, 49, 50, 56. The influences of such alternative splicing on the function of recombinant heteromeric NMDA receptors has yet to been studied in detail. However, the NR2 subunit of recombinant heteromeric NR1–NR2 NMDA receptors exerts a large influence on receptor functions, such as channel kinetics, sensitivity to Mg2+ blockade and ligand affinities 6, 18, 23, 26, 34, 35. The results of such studies on heteromeric recombinant NMDA receptors, considered together with the CNS distributions of the mRNAs encoding the NR2 subunits 18, 34, 35and NR1 splice variants 27, 28, 47, strongly suggest that the regional and developmental heterogeneity of endogenous NMDA receptor properties [33]is a consequence of regionally and developmentally different NR1–NR2 subunit combinations.

However, the confidence in NR1 and NR2 mRNA expression as a measure of subunit abundance has recently been undermined by the observation that cultured phaeochromocytoma PC12 cells and neuroblastoma Y79 cells express NMDA receptor subunit mRNAs but not the encoded proteins 21, 48. The distribution and properties of the endogenous subunit proteins should therefore be confirmed directly. Rabbit polyclonal antibodies have recently been raised against the rat NR1 splice variants 2, 5, 8, 39, 46and the four NR2 subunits 4, 21, 42, 46, 53, 55and have been used to examine properties and expression of the NR1 and NR2 antigens. In these reports, generally one or two NR2 subunits were compared and only one study [54]simultaneously compared the regional adult expression of all four NR2 subunits. A comprehensive, simultaneous examination of all four rat NR2 subunits, their regional and developmental expression and their properties in other species has not yet been published. Mouse monoclonal antibodies against the NR2 subunits have also not yet been reported. As part of our continuing investigations on glutamate-gated ion channels, we have generated mouse monoclonal antibodies specific for the N- and C-terminal regions of the four rat NR2 subunits and used them to study properties of these proteins. Part of this study has been presented in abstract form [25].

Section snippets

Generation of antibodies

Regions (≈120–200 amino acids in length) were selected from the N- and C-terminal domains of the four rat NR2 subunits. These regions were (according to published primary sequence numbering [18]); `NR2A.A3A4' amino acids 294–407, `NR2A.C1C2' 915–1048, `NR2A.C3C4' 1317–1443, `NR2B.A' 198–387, `NR2B.C1C2' 909–1046, `NR2B.C3C4' 1325–1461, `NR2C.A' 220–359, `NR2C.C3C4' 1088–1224, `NR2D.A' 184–381 and `NR2D.C3C4' 1080–1217. The DNA sequences encoding these regions were amplified by PCR from the

Molecular sizes and specificity

Antibodies recognising the NR2 subunits were initially identified on immunoblots of proteins from adult rat forebrain (NR2A and NR2B), adult rat cerebellum (NR2C) or neonatal rat brain (NR2D) (Fig. 1). Antibodies were selected by their affinity for proteins corresponding to the molecular weights calculated from the coding sequences of the NR2 subunits 18, 34. Optimal antibody concentrations covered a wide range (Table 1) and additional bands were observed less often with antibodies directed

Discussion

Specific mouse monoclonal antibodies were generated against N-and C-terminal sequences of the rat NR2 subunit proteins. As observed on immunoblots of specifically transfected HEK293 cells (Fig. 3), subunit specificity was achieved, even between the closely related subunit pairs NR2A and -2B, and NR2C and -2D 18, 34. In blots of brain membrane proteins some other proteins were occasionally detected, especially with the anti-N-terminal antibodies (Fig. 1, Table 1). These probably represent

Acknowledgements

We would like to thank Dr. H. Klafki, Schering, Berlin, and Dr. K.-H. Baumann, Novartis, Basel, for helpful discussions, and Mr. B. Kirchner, Boehringer Mannheim, for excellent technical assistance.

References (57)

  • D.J. Laurie et al.

    The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain

    Mol. Brain Res.

    (1995)
  • H. Monyer et al.

    Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

    Neuron

    (1994)
  • K. Okakura et al.

    Glutamatergic regulation of histamine release from rat hypothalamus

    Eur. J. Pharmacol.

    (1992)
  • M.A. Riva et al.

    Regulation of NMDA receptor subunit mRNA expression in the rat brain during postnatal development

    Mol. Brain Res.

    (1994)
  • R. Schoepfer

    The pRSET family of T7 promotor expression vectors for Escherichia coli

    Gene

    (1993)
  • D.G. Standaert et al.

    Alternatively spliced isoforms of the NMDAR1 glutamate receptor subunit: differential expression in the basal ganglia of the rat.

    Neurosci. Lett.

    (1993)
  • N.J. Sucher et al.

    Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells

    J. Biol. Chem.

    (1993)
  • H. Sugihara et al.

    Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing

    Biochem. Biophys. Res. Commun.

    (1992)
  • M. Yamazaki et al.

    Cloning, expression and modulation of a mouse NMDA receptor subunit

    FEBS Lett.

    (1992)
  • S. Akbarian et al.

    Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

    J. Neurosci.

    (1996)
  • C. Aoki et al.

    Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats

    J. Neurosci.

    (1994)
  • E. Audinat et al.

    Activity-dependent regulation of N-methyl-d-aspartate receptor subunit expression in rat cerebellar granule cells

    Eur. J. Neurosci.

    (1994)
  • A. Buller et al.

    The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition

    J. Neurosci.

    (1994)
  • G. Carmignoto et al.

    Activity dependent decrease in NMDA receptor responses during development of the visual cortex

    Science

    (1992)
  • P.L. Chazot et al.

    Immunological detection of the NMDAR1 glutamate receptor subunit expressed in human embryonic kidney 293 cells and in rat brain

    J. Neurochem.

    (1992)
  • M. Didier et al.

    Differential expression and co-assembly of NMDAζ1 and ϵ subunits in the mouse cerebellum during postnatal development

    NeuroReport

    (1995)
  • G.M. Durand et al.

    Cloning of an apparent splice variant of the rat N-methyl-d-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C

    Proc. Natl. Acad. Sci. USA

    (1992)
  • G.M. Durand et al.

    Splice variants of the N-methyl-d-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C

    Proc. Natl. Acad. Sci. USA

    (1993)
  • Cited by (208)

    • Neurosteroids

      2020, Hormonal Signaling in Biology and Medicine: Comprehensive Modern Endocrinology
    • Neurosteroids: Biosynthesis, Molecular Mechanisms, and Neurophysiological Functions in the Human Brain

      2019, Hormonal Signaling in Biology and Medicine: Comprehensive Modern Endocrinology
    View all citing articles on Scopus
    1

    Present address: Preclinical Nervous System Research, Novartis Pharma Inc., Room 821, Building S-386, CH-4002 Basel, Switzerland.

    2

    Present address: Laboratory for Molecular Pharmacology, University College London, Gower Street, London WC1E 6BT, UK.

    View full text